National survival trends of young adults with sarcoma
- 18 April 2005
- Vol. 103 (9) , 1891-1897
- https://doi.org/10.1002/cncr.20995
Abstract
BACKGROUND Young adults with cancer in the U.S. have had less improvement in survival than either younger patients or older patients. The authors attempted to determine whether similar deficits have occurred in young adults with sarcomas and, if so, then why. METHODS In 38,144 young adults with sarcoma who were diagnosed during 1975–1998 and were followed by the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results Program, the average annual percent change in 5‐year survival was derived as a function of patient age. National sarcoma treatment trial data were obtained on 3242 patients who were entered onto NCI‐sponsored trials during 1997–2002. RESULTS 1) For patients with bone and soft‐tissue sarcomas, except Kaposi sarcoma (KS), the least survival improvement occurred between age 15 years and age 45 years. For patients with KS, the pattern was reversed, with the greatest survival increase occurring among patients ages 30–44 years. 2) The lowest participation rate in NCI‐sponsored sarcoma treatment trials occurred in patients ages 20–44 years. For patients with KS, the highest accrual rate occurred in patients ages 35–44 years. 3) The age‐dependent survival improvement and clinical‐trial accrual patterns were correlated directly (soft‐tissue sarcomas, P < 0.005; bone sarcomas, P < 0.05; KS, P = 0.06), regardless of whether the accrual profile demonstrated a decline or a peak (KS) during early adulthood. CONCLUSIONS The lack of survival prolongation in patients age 15–44 years in the U.S. with non‐KS sarcomas may have been a result of their relative lack of participation in clinical trials. If this is true, then reversing the shortfall in survival among young adults with sarcomas, as was accomplished among patients with KS, should benefit from increased clinical trial availability, access, and participation. Cancer 2005. Published 2005 by the American Cancer Society.Keywords
This publication has 13 references indexed in Scilit:
- Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the NetherlandsLeukemia, 2004
- Localized Extremity Soft Tissue Sarcoma: Improved Knowledge With Unchanged Survival Over TimeJournal of Clinical Oncology, 2003
- Rhabdomyosarcoma in adultsCancer, 2003
- Treatment of Ewing sarcoma family of tumors: Current status and outlook for the futureMedical and Pediatric Oncology, 2003
- Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 TrialsJournal of Clinical Oncology, 2003
- Older adolescents with cancer in North AmericaPediatric Clinics of North America, 2002
- #50 Adolescent cancers in the United StatesJournal of Pediatric Hematology/Oncology, 1999
- National cancer clinical trials: Children have equal access; adolescents do notJournal of Adolescent Health, 1997
- OSTEOSARCOMAPediatric Clinics of North America, 1997
- Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment TrialsJNCI Journal of the National Cancer Institute, 1996